Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib + vinorelbine for previously treated HER2-positive metastatic breast cancer
ACTRN12610000347066Phase 2Completed
- Sponsor
- Breast Cancer Research Centre Western Australia
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lapatinib and vinorelbine in breast cancer, sponsored by Breast Cancer Research Centre Western Australia. Primary endpoint: Progression-free survival. Started Jul 2010; status: completed.
02
Drugs
lapatinibvinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12610000347066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000347066.